IMPACT-HCT Trial: Improving Goals of Care Conversations for Transplant Survivors

This study is looking at ways to help people who have had a hematopoietic cell transplant (HCT), also known as a bone marrow transplant, for blood cancers. We are testing if a website called Planning Advance Care Together (PACT) and/or patient navigation sessions can improve conversations about your future care goals. You might be able to join if you are 18 or older, had an HCT 1 to 5 years ago for a blood cancer, can speak and read English, and haven't completed all advance directives or had a goals of care conversation with your doctor. The study aims to see how many people enroll, complete the interventions, and finish the study assessments. The current recruitment status is unclear.

Study design
This study is interventional and will involve about 40 participants. You will be randomly assigned to one of four groups: PACT website plus patient navigation, patient navigation only, PACT website only, or standard care.
What's involved
You would interact with the PACT website over 4 weeks and/or have a 45-60 minute patient navigation session. You will also complete study assessments at baseline, and at 4 and 12 weeks after the intervention.
Compensation
Not stated in the trial record.
Follow-up
After completing the study intervention, you will be followed up at 4 and 12 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07052630

Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial

Recruiting
NAAges 18+InterventionalSupportive care
Fred Hutchinson Cancer Center
~40 participants
Updated 2026-06-05 on ClinicalTrials.gov
What's tested:Internet-Based InterventionPatient NavigationBest PracticeSurvey Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility (Rate of enrollment)
Measured over At baseline
+4 more outcomes measured
Hematopoietic and Lymphatic System Neoplasm

NCT07052630

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washingtonstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Megan Shen, PhD · PRINCIPAL_INVESTIGATOR · Fred Hutch/University of Washington Cancer Consortium

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Received a transplant for a hematologic malignancy
Current age 18 years of age or older
Currently 1 to 5 years after HCT
Ability to speak and read English
Has not completed all advance directives and/or had a goals of care (GOC) conversation with their physician
Access to the internet (via computer, tablet, or mobile device)

Exclusion

Unable to provide informed consent
Uncontrolled psychiatric conditions (confirmed through electronic health record \[EHR\] by study staff)
  • Feasibility (Rate of enrollment)At baseline

    Descriptive statistics will be run, including means and standard deviations for continuous data and frequencies and proportions for categorical data. Feasibility cutoffs will be based on prior research and include \>= 50% of eligible patients will enroll in the study.

  • Feasibility (Rate of completion of intervention components)At 12 weeks post intervention

    For the patient navigation component, this means that patients participate in the single patient navigation session with a health coach. For the Planning Advance Care Together (PACT) condition, this means that patients set up an account with the PACT website and engage in at least accessing the website. Feasibility cutoffs will be based on prior research and include \>= 50% of enrolled patients will adhere to and complete assigned intervention components and study-related assessments.

  • Feasibility (Rate of completion of study assessments)At baseline, and at 4 and 12 weeks post intervention

    Descriptive statistics will be run, including means and standard deviations for continuous data and frequencies and proportions for categorical data. Feasibility cutoffs will be based on prior research and include \>= 50% of enrolled patients will adhere to and complete assigned intervention components and study-related assessments.

  • Acceptability of interventionAt 4 weeks post intervention

    Will be measured using the 4-item Acceptability of Intervention Measure. Items are rated on a 5-point Likert scale. Acceptability will be defined as a median score of \>= 4.

  • Completion of advance directivesAt baseline, and at 4 and 12 weeks post intervention

    Questions asking patients whether they have completed a do not resuscitate (DNR) order, living will or identified a health care proxy. This item is scored as having no advance directives (0) to all advance directives completed (3). In addition to the primary outcome of advance directives (0 to 3 score), investigators will also examine each outcome separately (e.g., yes/no to completing a health care proxy) as secondary measures.